Drugs / Enoxalow
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01692158 | Mar → Nov 2013 | — | Azidus Brasil | Completed | No outcome recorded |
| Phase 1 | NCT01692171 | Feb → Oct 2013 | — | Azidus Brasil | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Enoxalow | “The hypothesis of this trial is that the test drug (Enoxalow® - T) pharmacodynamics parameters are similar to the comparator drug (Clexane® - C) in healthy subjects following...” NCT01692171 ↗1“Enoxalow (Heparin, Low-Molecular-Weight) - Blau Farmacêutica S/A.” NCT01692158 ↗ |